期刊文献+

胎儿生长受限的临床研究进展 被引量:3

Clinical Research Progress of Fetal Growth Restriction.
原文传递
导出
摘要 胎儿生长受限(fetal growth restriction,FGR)是围生期常见的并发症之一,发生率约为6.39%。FGR胎儿在围生期易出现缺氧、窒息、酸中毒等,对产程的耐受性差,围生儿死亡率较正常增高6~9倍。FGR患者生长及智力发育缓慢、滞后;成年后是发生内分泌代谢障碍、心血管疾病、阻塞性肺疾病、肾脏疾病和内分泌代谢障碍等疾病的高危人群。因此对FGR应及早发现,及早治疗,对已发生FGR者在宫内进行及时、有效的治疗就十分重要,对围生儿的预后也产生积极的影响。 Fetal growth restriction(FGR) is one of common complications in the perinatal period,with 6.39% of incidence.With poor tolerability of prolonged labor duration and mortality rate 6-9 times higer than that of normal fetus,FGR fetus in the perinatal period are easy to hypoxia,suffocation,acidosis,etc.They grow slowly in height and intelligence quotient,and may be high risk group with cardiovascular disease,obstructive lung disease,kidney disease,endocrine metabolic disorder and so on when they become adults.So,FGR fetus shoud be detected and treated early and timely.It will take an important effect on their prognosis to treat effectively and timely in intrauterin.
出处 《中国优生与遗传杂志》 2010年第10期123-125,共3页 Chinese Journal of Birth Health & Heredity
关键词 胎儿生长受限 研究进展 Fetal Growth Restriction(FGR) Research Progress
  • 相关文献

参考文献24

  • 1Holemans K, Aerts L, Van Assche. Fetal growth restriction and consequences for the offspring in animalmodels [ J ]. J Soc Gynecol Invest, 2003,10 : 392.
  • 2刘胜兰,涂少华,叶元康,李怀芳.孕妇支原体感染与低出生体重儿的红霉素干预实验[J].实用妇产科杂志,2001,17(6):355-356. 被引量:3
  • 3闻良珍,熊锦文.胎儿宫内发育迟缓的病理生理变化[J].中国实用妇科与产科杂志,2002,18(1):19-20. 被引量:58
  • 4Difederico E,Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall[ J]. Am J Pathol, 1999,155 : 293 - 301.
  • 5Boutsikou T,et al. Soluble vascularendothelialgrowth factor receptor -1 in intrauterine growth restricted fetuses and neonates[ J]. EarlyHaman Development,2006,82 : 235 - 239.
  • 6Aubard Y, Darodes N, Cantaloubem. Hyperhomocysteinemia and pregnancy review of our present understanding and therapeutic implications [ J ]. Eur J obstet Gneco! Reprod ,2000,93 : 157.
  • 7Matsubara F, Kida M, Tamakoshi A, et al. Maternal active and passive smoking and fetal growth : a prospective study in Nagoya, Japan [ J ]. J Epidemiol,2000,10:335.
  • 8Garite TJ, Clark RH, Elliott JP, et al. Twins and triplets: the effect of plurality and growth on neonatal outcome compared with singleton infants [ J ]. Am J Obstet Gynecol,200g, 191 ( 3 ) : 700 - 707.
  • 9Sheiner E. Maternal faeftors associated with Sereritry of birth defects [ J]. Int J Gynecol Obstet, 19/99,64:227 - 232.
  • 10Regnault TR, de Vrijer B, Galan HL, et al. The relationship between transplaecntal O2 diffusion and placental expression of P1GF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction [ J ]. J Physiol,2003,550 ( Pt2 ) :641 - 656.

二级参考文献10

  • 1任慕兰,沈毓娟,鲁荣绥,程云英.孕妇生殖道支原体感染的治疗[J].铁道医学,1995,23(2):119-119. 被引量:3
  • 2叶辉 武济民 等.支原体对24种抗菌药体外敏感性研究[J].中华流行病杂志,1998,19(3):56-56.
  • 3余敏群 尹卫国 等.8种抗菌药物体外解脲支原体与人型支原体的活性研究[J].中华流行病杂志,1998,19(3):73-73.
  • 4Bellart J, Gilabert R, Fontcuberta J, et al. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. Am J Perinatol,1998, 15:1581-1585.
  • 5Dulitzki M, Pauzner R, Langevitz P, et al. Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies. Obstet Gynecol, 1996,87:380-383.
  • 6Schneider D, Heilmann L, Harenberg J. Placental transfer of low-molecular weight heparin. Geburtshilfe Frauenheilkd, 1995,55:93-98.
  • 7Harding R,Cock ML,Louey S,et al. The compromised intra-uterine environment: implications for future lung health. Clin Exp Pharmacol Physiol, 2000,27:965-974.
  • 8Bar J, Mashiah R, Cohen-Sacher B, et al. Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thromb Res, 2001,101:235-241.
  • 9Dimitrakakis C, PapageorgiouP, Papageorgiou I,et al. Absence of transplacental passage of the low molecular weight heparin enoxaparin. Haemostasis, 2000,30:243-248.
  • 10吴移谋,余敏君,尹卫国,朱翠明,刘腾飞,曾铁兵,谭立志.从临床标本中定量检测泌尿生殖道支原体耐药性的研究[J].中华医学检验杂志,1998,21(6):335-337. 被引量:99

共引文献94

同被引文献25

  • 1马玲 李萍.胎儿生长受限的治疗进展.中国优生优育,2010,16(2):70-72.
  • 2丰有吉,沈铿.胎儿生长受限一妇产科学[M].2010.104-107.
  • 3Figueras F, Gardos i J. Intrauterine growth restriction: new con- cepts in antenatal surveillance, diagnosis and management. Ameri- can J Obstet & Gyneeol, 2011, 204:288 -300.
  • 4Halliday HI..Neonatal management and long- term sequelaa Best Prac- tice & Research Clinical Obstetrics and Gynecology, 2009, 23c 871- 88Q.
  • 5Dorling J, Kern pley S, Leaf A. Feeding growth restricted preterm iIffants with abnormal antenatal Doppler results. Arch Dis Child Fetal Neon at al Ed, 2005, 90: F359- F363.
  • 6Singhal A, Cole TJ, Few t rell M, et al. Promotion of faster weight gain in infants born small for gestation age: is there an adverse effect on later blood pressure. Circation, 2007, 1'15: 213- 220.
  • 7Jacobsson B, Ahlin K, Francis A, et al. Cerebral palsy and re- stricted owth status at birth: population-based case -control study. Br J Obstet Gynecol, 2008, 115: 1250-1255.
  • 8Gardosi J.Intrauterine growth restrictiorr new standards for assessing adverse out coma Best Pract Res Clin Obstet Gynecol, 2009, 23:. 741- 749.
  • 9ACOG practice bullet in intrauterine growth restriction [J].I n t J Gynecol Obstet, 2001, 72: 85-96.
  • 10Lindqvist PG, Molin J. Does antenatal identification of small for gestational age fetuses signif -icantly improve their outcome? Ultrasound Obstet Gynecol, 2005, 25: 258- 264.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部